although-the-indian-vaccine-sector-is-plagued-with-regulatory-glitches-it-has-a-substantial-pipeline-to-look-forward-to

India's vaccine future looks bright despite hurdles

  • India
  • |
  • Analysis
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

The Indian vaccine industry has been in the past few years following close on the footsteps of the Indian pharma sector. The vaccine industry has been making concerted... Read more

indian-vaccine-firms-are-gearing-up-to-develop-and-commercialize-several-vaccines-not-just-for-the-world-but-also-for-the-domestic-market

What are the new vaccines on the horizon for India?

  • India
  • |
  • Analysis
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

Vaccines are considered among the most important medical inventions made by man. Indian vaccine manufacturers, who are well known across the world for their quality... Read more

the-indian-vaccine-industry-has-played-a-significant-role-to-help-india-maintain-its-zero-polio-record

How has India been able to keep Polio at bay?

  • India
  • |
  • Analysis
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

India, which was once considered as the world's epicenter of polio, successfully interrupted the transmission of the wild polio virus and completed one year without... Read more

imatinib-mesylate-branded-by-novartis-as-gleevec-in-the-us-and-as-glivec-in-china-and-india

All you need to know about Glivec

  • India
  • |
  • Analysis
  • |
  • By Manasi Vaidya
  • |
  • 1 Comment

What is Glivec? Glivec or imatinib mesylate is the first of a class of drugs that specifically inhibits a target enzyme, receptor tyrosine kinase, which is characteristic... Read more

vaccine-rotavac

Phase III trial of $1 vaccine RotaVac completed

  • India
  • |
  • News
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

Pune: The phase III trial of RotaVac, India's first indigenously developed rotavirus vaccine, has been completed and the data is presently being analyzed for further... Read more

dr-gautam-daftary-managing-director-bharat-serums-and-vaccines-india

Dr Gautam Daftary: The Indian biologics pioneer

  • India
  • |
  • Influencers
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

Indian company Bharat Serums and Vaccines boasts of a product portfolio that includes many firsts in India and the world and has carved out a prominent space in... Read more

swasthya-adhikar-manch-s-public-interest-litigation-pil-leads-supreme-court-of-india-to-reprimand-health-ministry-and-cdsco

Indian apex court raps govt over clinical trial data

  • India
  • |
  • Analysis
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

Giving a clear call for accountability, the Supreme Court of India, on January 3, 2013, sternly reprimanded the Ministry of Health and Family Welfare and Central... Read more

why-is-the-rate-of-approval-of-biologics-declining-in-india

Approval rate for biologics drop in India

  • India
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

The biopharma sector, which contributes about 60 percent of the Indian biotechnology industry, has been witnessing a compound annual growth rate (CAGR) of 21.63... Read more

boon-or-bane-india-s-patent-wars-and-its-changing-scenario

What is up with the Indian patent scenario?

  • India
  • |
  • Analysis
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

To say that the last few months have been tumultuous for the India pharma patent landscape would be an understatement. Indian pharma has witnessed a number of landmark... Read more

can-india-become-a-global-drug-discovery-collboration-hot-spot

Global collaborations is the way forward for drug discovery...

  • India
  • |
  • Analysis
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry services to big pharma through a multitude of... Read more

technologies-like-the-one-used-on-the-veredus-veremtb-image-lab-on-chip-device-are-revolutionizing-the-diagnostic-industry

Lab-on-chips usher in an era of shrinking labs

  • Singapore
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Gone would be the days when patients will have to walk-in to their pathologists for diagnosis of a disease and wait for several weeks to get the result for tests... Read more

denmark-provides-excellent-opportunities-for-researchers-such-as-the-national-biobank-that-stores-blood-samples-of-danish-children-born-after-1982

National biobank of Denmark stores 15 mn samples

  • Europe
  • |
  • News
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

Singapore: Denmark has been accelerating its efforts towards promoting life science research in the country in a substantial way. One of the initiatives taken by... Read more

mr-senya-imamichi-md-shimadzu-analytical-india

Shimadzu India aims at 15-20% growth

  • India
  • |
  • Influencers
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

With a view of expanding their customer base, Shimadzu Analytical India has been taking concrete steps towards connecting with their customers through various initiatives.... Read more

mr-ranjit-shahani-vice-chairman-and-md-novartis-india-and-president-organization-of-pharmaceutical-producers-of-india-oppi

Novartis: Compulsory licenses will not expand access to...

  • India
  • |
  • Influencers
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

In a patent suit that has grabbed eyeballs across national and international media, the Glivec case has become more than just another piece of litigation. While... Read more

dr-satyen-sanghavi-cso-regenerative-medical-services-rms-regrow

India is on the verge of a major stem cell breakthrough...

  • India
  • |
  • Influencers
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

Started with an initial investment of Rs4.5 crore two years ago, Regenerative Medical Services (RMS Regrow Regrow) is a now Rs20 crore company focused on stem cell... Read more

Previous 1 3

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X